CONDUIT PHARMACEUTICALS INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Conduit Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q3 2024.
  • Conduit Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$650K, a 121% decline year-over-year.
  • Conduit Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$816K, a 654% decline year-over-year.
  • Conduit Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was $4.73M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$816K -$650K -$3.71M -121% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.89M -$2.24M -$1.4M -165% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-11-14
Q1 2024 $4.29M -$597K -$440K -280% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-11-14
Q4 2023 $4.73M $2.67M +$4.58M Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $147K $3.06M +$3.08M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$2.93M -$845K -$1.04M -541% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-11-14
Q1 2023 -$1.89M -$157K -$167K -1642% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-11-14
Q4 2022 -$1.73M -$1.91M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$23K Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-11-21
Q2 2022 $192K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $10.2K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.